# A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)

> **NCT07334886** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]Ulonivirine

## Key facts

- **NCT ID:** NCT07334886
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-17
- **Primary completion:** 2025-11-11
- **Final completion:** 2025-11-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07334886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07334886, "A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07334886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*